ZLD1039 T29231
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
ZLD1039 is a potent, highly selective, and orally bioavailable inhibitor of EZH2. The inhibition of EZH2 methyltransferase activity decreased global histone-3 lysine-27 (H3K27) methylation, and reactivated silenced tumor suppressors connected to increased
CAS nr:
1826865-46-6
Purity:
98%
Molecular Weight:
612,82
SMILES:
O=C(NCC1=C2CCCCC2=C(C)NC1=O)C3=CC(C4=CC=C(N5CCN(C)CC5)N=C4)=CC(N(CC)C6CCOCC6)=C3C
Formula:
C36H48N6O3
Pathway:
Target:
